Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Immunic Inc.

    NASDAQ: IMUX · Real-Time Price · USD
    0.92
    -0.05 (-5.51%)
    At close: May 21, 2025, 3:59 PM
    0.95
    3.40%
    After-hours: May 21, 2025, 07:54 PM EDT
    -5.51%
    Bid 0.92
    Market Cap 88.15M
    Revenue (ttm) n/a
    Net Income (ttm) -96.4M
    EPS (ttm) -0.95
    PE Ratio (ttm) -0.97
    Forward PE -1.42
    Analyst Buy
    Ask 0.97
    Volume 763,271
    Avg. Volume (20D) 882,460
    Open 0.94
    Previous Close 0.97
    Day's Range 0.90 - 0.96
    52-Week Range 0.83 - 2.11
    Beta 1.73

    About IMUX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol IMUX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for IMUX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 weeks ago
    -22.65%
    Immunic shares are trading lower. The company repo... Unlock content with Pro Subscription
    3 months ago
    +12.38%
    Immunic shares are trading higher after the company announced its ORAL IMU-856 demonstrated a dose-dependent increase of GLP-1 in celiac disease patients.
    news image

    3 weeks ago · proactiveinvestors.com

    Immunic reports reduced disability worsening in progressive multiple sclerosis trial

    Immunic Inc (NASDAQ:IMUX) has reported promising results from its Phase 2 CALLIPER trial of vidofludimus calcium, which showed a 30% reduction in the risk of 24-week confirmed disability worsening in ...

    news image

    3 weeks ago · seekingalpha.com

    Immunic: A Strong Buy With Imminent Data Readout That Should Send Shares Higher

    Immunic's lead asset, vidofludimus calcium, shows promise in MS trials, with positive interim results and potential for commercialization if upcoming catalysts deliver. Despite high volatility and rec...

    news image

    1 month ago · proactiveinvestors.com

    Immunic announces pricing of $5.1M direct offering to support clinical pipeline

    Immunic Inc (NASDAQ:IMUX) has priced its $5.1 million registered direct offering led by Aberdeen Investments, selling 5.67 million shares at $0.90 each. The biotechnology company, which is advancing o...

    news image

    2 months ago · proactiveinvestors.com

    Immunic provides MS research update – ICYMI

    Immunic Inc (NASDAQ:IMUX) earlier this week provided an update on its multiple sclerosis (MS) drug, vidofludimus calcium, highlighting its potential to address both inflammation and neuroprotection. D...

    news image

    2 months ago · proactiveinvestors.com

    Biotechs challenge big pharma with new oral weight loss therapies

    With the smash success of glucagon-like peptide-1 (GLP-1) agonists as a treatment for obesity, pharmaceutical giants and emerging biotechnology firms alike are working to develop an equally effective ...

    news image

    2 months ago · proactiveinvestors.com

    Immunic to highlight vidofludimus calcium's potential as MS therapy at upcoming forum

    Immunic Inc (NASDAQ:IMUX) announced that it will present key data for its investigational drug vidofludimus calcium in two poster presentations at the Americas Committee for Treatment and Research in ...

    news image

    2 months ago · proactiveinvestors.com

    Immunic drug candidate may offer new obesity treatment - ICYMI

    Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive to discuss the company's latest findings on IMU-856, a drug candidate initially studied for celiac disease. New data suggests that IMU-856...

    Add to Watchlist